CDKN2BAS1/ANRIL, located in the 9p21 chromosomic region, has been reported in numerous studies as a genetic risk locus for CAD, intracranial aneurysms and diverse cardiometabolic disorders (32). This evidence concerns the gene CDKN2B-AS1 and Dilatation of the cerebral artery.